Cyclooxygenase (COX)-inhibiting drug reduces HSV-1 reactivation in the mouse eye model

Shiro Higaki1, Keizo Watanabe, Motoki Itahashi

  • 1Department of Ophthalmology, Kinki University School of Medicine, Osaka-Sayama, Japan. higaki@ganka.med.kindai.ac.jp

Current Eye Research
|March 11, 2009
PubMed
Abstract

Insights

Bromfenac sodium eye drops showed potential in suppressing herpes simplex virus type 1 (HSV-1) reactivation in a mouse model. Further research is needed to confirm its efficacy in clinical settings.

Area of Science:

  • Ophthalmology
  • Virology
  • Pharmacology

Background:

  • Herpes simplex virus type 1 (HSV-1) establishes lifelong latency in sensory neurons.
  • Reactivation of HSV-1 can lead to ocular disease, including herpetic keratitis.
  • Cyclooxygenase (COX) inhibitors are explored for their potential antiviral properties.

Purpose of the Study:

  • To investigate the efficacy of COX inhibitors in suppressing HSV-1 reactivation.
  • To evaluate bromfenac sodium, pranoprofen, and etodolac for their ability to prevent HSV-1 recurrence in a mouse model.

Main Methods:

  • BALB/c mice with latent HSV-1 infection were treated with bromfenac sodium, pranoprofen, etodolac, or saline eye drops.
  • Latent HSV-1 was reactivated, and ocular surface swabs were cultured for infectious virus.
  • Viral loads in eyes and trigeminal ganglia (TGs) were quantified using real-time PCR.

Main Results:

  • Bromfenac sodium eye drops demonstrated a statistically significant reduction in positive HSV-1 swab results compared to saline (p = 0.033).
  • No significant differences in viral DNA levels were observed in the eyes or TGs among the drug-treated groups and the saline control group.
  • Pranoprofen and etodolac did not show significant suppression of HSV-1 reactivation compared to the saline group.

Conclusions:

  • Bromfenac sodium eye drops exhibit potential in suppressing HSV-1 reactivation.
  • Current COX inhibitors tested did not significantly reduce viral loads in ocular tissues or TGs during reactivation.
  • Further studies are warranted to elucidate the precise mechanisms and clinical applicability of bromfenac sodium for HSV-1 suppression.

Related Concept Videos

Herpes01:28

Herpes

Herpes simplex type 1 (HSV‑1) is a widespread pathogen responsible for orolabial lesions. It is an enveloped, double-stranded DNA (dsDNA) virus belonging to the family Herpesviridae. Once the virus infects a host cell, its double‑stranded DNA genome is delivered into the nucleus, where a coordinated cascade of immediate‑early, early, and late gene expression directs viral DNA replication, structural protein synthesis, and virion assembly. After primary infection of epithelial cells, HSV-1...
Genital Herpes01:23

Genital Herpes

Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...